General Medical Clinic
06/30/2009 13:00


CC
F/U BPH and Parkinson disease.

Subjective



Parkinson disease
Tremor and bradykinesia improved significantly; pt feels his symptoms are now adequately controlled again.  He is able to get around more quickly now and does not spill liquid when drinking from a cup.


Benign prostatic hyperplasia
BPH symptoms much improved per patients report.  He is satisfied with his current symptoms and is not interested in more aggressive treatment at this time.



Allergies
NSAIDs: severe abdominal pain.


PMH
Hypertension
Parkinson disease
Depression
Benign prostatic hyperplasia
Osteoarthritis
Hyperlipidemia
Coronary Artery Disease

PSurgHx
none

FamHx
Mother died of CVA at age of 64
Father died of MI at age 53


SocHx
Widower (wife died several years ago from breast cancer).
Currently working at a small grocery store in town.
Has 1 child that lives in another state.
Denies alcohol and illicit drug use (has never used); he does smoke 1 ppd of cigarettes and has done so for about 40 years (40-pack-year history).


Medications
Hydrochlorothiazide 12.5 mg PO daily #90, 3 refills
Carbidopa +levodopa 25mg/100mg tablet  1 Tablet PO q6h #360, 3 refills
Acetaminophen 1000 mg PO daily #90, 3 refills
Tamsulosin 0.8 mg PO daily #90, 3 refills
Aspirin 81 mg PO daily #90, 3 refills
Citalopram 40  mg PO daily #90, 3 refills
Simvastatin 80 mg PO daily #90, 3 refills

Review of Systems
As noted above.

Objective
VITALS:
	SBP:137, DBP:81, Pulse:76, POx:97, Temp:98.1, RR:16, Weight:188, Height:73, BMI:25
EXAM: 
GEN: NAD
NEURO: tremor and bradykinesia are less pronounced today, but both are still present.

Assessment and Plan

Parkinson disease
Assessment
Control of Parkinson disease is improved.
Sinemet dose increased last month; bradykinesia and tremor now adequately controlled.
Plan
Continue Sinemet 25/100 mg 1 Tablet q6h to decrease and Tremor (parkinsonian)

Benign prostatic hyperplasia
Assessment
Control of Benign prostatic hyperplasia is improved.
IPSS-AUA decreased to 14.  Post-void residual done in office today revealed 126 mL residual, which is within goal range for this patient.
Plan
Continue Tamsulosin 0.8 mg daily to decrease  IPSS-AUA, and decrease  post-void residual volume

Misc.
Plan
RTC 6 months.


Author:  IM_Doctor